background: In mammalian follicles, oocytes are arrested at the diplotene stage of prophase I until meiotic resumption following the LH surge. Recently, C-type natriuretic peptide (CNP), encoded by natriuretic peptide precursor type C (NPPC) was found to suppress mouse oocyte maturation by promoting cyclic guanosine 5 ′ -monophospate (cGMP) production in cumulus cells. However, regulation of NPPC/CNP expression during the pre-ovulatory period and their regulation by the LH surge have not been investigated.
Introduction
In mammalian follicles, primary oocytes enter meiosis but are arrested at the diplotene stage of prophase I. The oocytes stay in this dormant state for months and years until the pre-ovulatory stage. In response to the pre-ovulatory LH surge, the germinal vesicle of the oocytes in pre-ovulatory follicles undergoes germinal vesicle breakdown (GVBD), followed by first polar body extrusion. Although the pre-ovulatory surge of LH is the primary event responsible for the induction of maturation of the oocyte, LH and its surrogate hCG do not act directly on the oocyte due to the absence of functional LH receptors in germ cells (Peng et al., 1991) . Instead, actions of LH/hCG are mediated either by paracrine factors secreted by LH-responsive theca and mature granulosa cells or by the transport of cellular messengers from granulosa/cumulus cells to oocytes through intercellular gap junctions (Gilula et al., 1978) .
The prolonged arrest of oocytes in the meiotic prophase I and subsequent resumption of meiosis is correlated with intra-oocyte levels of the second messenger cyclic adenosine 3 ′ , 5 ′ -monophosphate (cAMP). Based on mouse studies, meiotic arrest of the oocyte is most likely maintained by cAMP generated by oocyte adenylyl cyclase controlled by the constitutive activity of G-protein coupled receptor 3 (GPR3) and GPR12 via the stimulatory G-protein (Mehlmann et al., 2004; Hinckley et al., 2005) . Although LH stimulates cAMP production in follicular somatic cells, a decrease in intra-oocyte cAMP level is required for meiotic resumption (Tsafriri and Pomerantz, 1986) . Following the pre-ovulatory LH surge, increases of an oocyte-specific phosphodiesterase 3A (PDE3A) lead to decreased cAMP concentrations in oocytes and thereby initiates meiosis resumption (Richard et al., 2001) . However, the exact mechanism underlying the regulation of PDE3A activity in oocytes by the pre-ovulatory LH surge is unclear.
Earlier studies demonstrated that removal of cumulus cell -oocyte complexes (COCs) from pre-ovulatory follicles led to spontaneous resumption of meiosis, consistent with a role of granulosa cell factors in maintaining meiotic arrest of oocytes. Indeed, granulosa cells secrete an oocyte maturation inhibitor (OMI) into the follicular fluid. This factor is capable of suppressing oocyte maturation by acting through cumulus cells and biochemical analyses indicated that OMI is a peptide of ,2000 dalton (Tsafriri and Pomerantz, 1984) . Consistent with the original evidence, a recent study indicated that C-type natriuretic peptide (CNP) of 2000 dalton, encoded by natriuretic peptide precursor type C (NPPC) was produced by mural granulosa cells and promoted cyclic guanosine 5 ′ -monophospate (cGMP) production in cumulus cells through its cognate receptor, natriuretic peptide receptor 2 (NPR2, a guanylyl cyclase) (Zhang et al., 2010) . Cumulus cell cGMP could be transported to oocytes via gap junctions, and elevation of intra-oocyte cGMP levels could inhibit PDE3A, leading to sustained elevation of intra-oocyte cAMP levels (Norris et al., 2009; Vaccari et al., 2009) . The important role of elevated intra-oocyte cAMP levels in suppressing oocyte meiotic progression has been substantiated in several mammalian species using PDE3 inhibitors [rodents: (Tsafriri et al., 1996; Wiersma et al., 1998) ; bovine: (Thomas et al., 2002) ; primates, monkeys: (Jensen et al., 2002) and human: (Nogueira et al., 2003) ]. Although oocyte-derived paracrine factors were found to increase the transcript levels of NPR2 in cumulus cells (Zhang et al., 2010) , regulation of NPPC gene expression and CNP secretion during the pre-ovulatory period and their regulation by the LH surge have not been characterized. Based on the genome-wide analysis of DNA microarray data sets using samples from periovulatory ovaries, we found increases in NPPC expression in granulosa cells during pre-ovulatory follicle growth in mice and a rapid decline induced by the pre-ovulatory LH/hCG stimulation. In human ovaries, we further demonstrated decreases in CNP levels in ovarian follicular fluid following treatment of patients with an ovulatory dose of hCG. Furthermore, we confirmed the suppression of meiotic progression by CNP using cultured mouse COCs and pre-ovulatory follicles.
Materials and Methods

DNA microarray analyses
Female B6D2F1 mice (n ¼ 108) (Charles River Laboratories, Wilmington, MA, USA) were injected at 21 days of age with Humegon (7.5 IU per animal, Organon, Oss, Netherlands) to stimulate follicular growth. Forty-eight hours later, some animals were treated intraperitoneal (i.p.) with Pregnyl (5 IU per animal, Organon) to induce ovulation. Ovaries were dissected from animals killed bi-hourly after Humegon treatment (three mice per group) and hourly after Pregnyl treatment (one mouse per group) for RNA extraction (TRIzol, Invitrogen, Carlsbad, CA, USA). Aliquots of 6 mg of total RNA at 1 mg/ml for one-chipset hybridization were stored at 2808C. Samples were hybridized to the Affymetrix mouse MGU74v2 arrays A, B and C according to standard Affymetrix protocols. The pooled follicular phase samples were hybridized in duplicate, and the post Pregnyl samples were single determinations (Kawamura et al., 2005) .
Animals
Ovarian samples were obtained from female B6D2F1 mice at 25 days of age (CLEA Japan, Tokyo, Japan; Charles River Laboratories) treated with a single i.p. injection of 7 IU of pregnant mare serum gonadotrophin (PMSG; Calbiochem, Cambridge, MA) followed at 48 h later with 10 IU of hCG (ASKA Pharmaceutical, Tokyo, Japan) administrated i.p. to stimulate follicle maturation and ovulation, respectively. The care and use of animals was approved by the Animal Research Committee, Akita University School of Medicine and Stanford University School of Medicine.
Follicular fluid sampling from patients
Follicular fluid samples were obtained from six patients, aged 35 -40 years, who underwent conventional IVF-embryo transfer or ICSI. Controlled ovarian hyperstimulation was performed with the long GnRH agonist protocol. Briefly, patients were treated with hMG (Kowa pharmaceutical, Tokyo, Japan, or ASUKA pharmaceutical) after pituitary suppression with a GnRH agonist (Nasanyl: Pfizer, Tokyo, Japan) started in the midluteal phase of the preceding cycle. Ovulation was triggered with hCG when the leading follicle reached 18 -20 mm in diameter measured by transvaginal ultrasound. After 36 h of hCG administration, transvaginal oocyte aspiration was performed with ultrasound guidance. Follicular fluid samples were collected from the first aspirated follicle of each ovary to avoid mixing of fluids from different follicles. For follicular fluid before the endogenous LH surge, samples were obtained at laparotomy from 15 patients, aged 31 -42 years, with uterine leiomyoma exhibiting normal menstrual cycles. Large antral follicles (15 -20 mm in diameter) were aspirated individually before the LH surge, and the menstrual stage was confirmed based on urinary LH levels and ovarian ultrasonography. All samples were obtained at Akita University Hospital with informed consent from patients and approval from the Human Subject Committee of Akita University.
In the follicular samples from conventional IVF-embryo transfer or ICSI patients, the presence of matured oocytes at metaphase II (MII) was confirmed. For all follicular aspirates, blood contamination was determined by visual inspection. Only blood-free follicular fluid samples were centrifuged at 800g for 15 min, and the supernatants were stored at 2808C before ELISA analyses.
Real-time RT -PCR
For quantitative real-time RT-PCR of mouse samples, whole ovaries, germinal vesicle stage oocytes, cumulus cells and mural granulosa cells were collected from ovaries of PMSG-treated immature mice at 46 h after treatment (Kawamura et al., 2004 (Kawamura et al., , 2005 and different times after hCG treatment. COCs were obtained by puncturing the largest follicles of pre-ovulatory ovaries, and denuded oocytes were separated from cumulus cells by mechanical pipetting. Granulosa cells were obtained separately by puncturing large antral follicles, followed by the removal of COCs. Quantitative realtime RT-PCR of transcript levels in whole ovaries and different ovarian cell types were performed using a Smart Cycler (Takara, Tokyo, Japan) as described (Kawamura et al., 2005 (Kawamura et al., , 2007 . The primers and hybridization probes for real-time PCR of NPPC, NPPA and histone H2a are as follows:
To determine the copy number of target transcripts, cloned plasmid cDNAs for individual gene were used to generate a calibration curve. Purified plasmid cDNA templates were measured, and copy numbers were calculated based on absorbance at 260 nm. A calibration curve was created by plotting the threshold cycle against the known copy number for each plasmid template diluted in log steps from 10 7 to 10 2 copies. Each run included standards of diluted plasmids to generate a calibration curve, a negative control without a template, and samples with unknown mRNA concentrations. Data were normalized based on histone H2a transcript levels.
COC and pre-ovulatory follicle cultures
COCs were obtained by puncturing the largest follicles from pre-ovulatory ovaries. COCs were cultured in minimum essential media (MEM, Invitrogen) with 3 mg/ml bovine serum albumin (Sigma, St. Louis, MO, USA), 100 U/ml penicillin and 100 mg/ml streptomycin in the presence or absence of 100 nM atrial natriuretic peptide (ANP) (Sigma), encoded by NPPA, different doses of CNP (Sigma), or zaprinast (Sigma) for 4 h at 378C in 5% CO 2 /95% air. After culture, cumulus cells were removed by mechanical pipetting and the occurrence of GVBD was examined under a Hoffman modulation contrast microscopy (Nikon Inc., Tokyo, Japan). Pre-ovulatory follicles were excised from mouse ovaries at 46 -48 h after PMSG treatment (Tsafriri et al., 1996; Kawamura et al., 2004) . were pretreated with different doses of CNP or 10 mM ANP for 1 h before treatment with or without 1 mg/ml hCG (American Pharmaceutical Partners, Inc., Schaumburg, IL, USA) in Leibovitz's L-15 medium (Invitrogen). The vials were flushed at the start of the culture with O 2 /N 2 (at a 1:1 ratio), sealed, and cultured at 378C with gentle shaking for 8 h. After culture, follicles (10 per group) were collected for real-time RT -PCR analyses to examine the hCG regulation of NPPC and NPPA transcript levels. For some follicles, COCs were isolated, and, after cumulus cell removal by mechanical pipetting, oocytes were examined for the occurrence of GVBD.
Measurement of cumulus cell and oocyte cGMP levels
At 1 h after culture of COCs as described above, groups of 100 -150 COCs were mechanically dissociated by pipetting with a small bore glass pipette in MEMa medium (Invitrogen) containing 0.2 mM 3-isobutyl-1-methylxanthine (IBMX) (Sigma) to obtain both the cumulus cells and the associated oocytes. IBMX, a non-selective PDE inhibitor, was used to inhibit endogenous PDE activities during preparation of the assay. After three washes in phosphatebuffered saline, samples were solubilized in 100 ml of 0.1 M HCl on ice for 10 min, then snapped frozen in liquid nitrogen, and stored at 2808C until assay. For enzyme immunoassay (EIA) measurement of cGMP levels, samples were thawed and centrifuged at 14 000g for 5 min, and the supernatant was collected to a glass tube and dried at 608C. Levels of cGMP in the reconstituted samples were quantified using a cGMP EIA kit (Cayman Chemicals, Ann Arbor, MI, USA) according to the manufacturer's instructions.
Measurement of ovarian CNP levels
For EIA measurement of the CNP, ovaries from PMSG-primed mice were obtained at different times after hCG treatment and boiled for 5 min in five volumes of water to inactivate intrinsic proteases. The solution was then adjusted to 1 M AcOH and 20 mM HCl. Ovaries were homogenizing with a Polytron mixer (VWR International, West Chester, PA, USA) before centrifugation at 20 000g for 30 min at 48C. The supernatant of the extracts was subjected to acetone precipitation at a concentration of 66% acetone. After removing the precipitates by centrifugation for 30 min at 3000g, acetone in the supernatant was evaporated and extracted peptide samples dissolved in water before EIA analyses. Levels of CNP in the reconstituted mouse samples and the supernatant of human follicular fluid samples were quantified using a CNP EIA kit (mouse samples, Phoenix Pharmaceuticals, Inc., Burlingame, CA, USA) and a CNP ELISA kit (human samples, Uscn Life Science Inc. Wuhan, China), respectively according to the manufacturer's instructions.
Statistical analysis
Statistical analysis was carried out by using the Mann -Whitney U-test for paired comparison and the one-way analysis of variance followed by Fisher's protected least significant difference for multiple group comparison. Results are presented as mean + SEM of at least three separate experiments.
Results
The pre-ovulatory LH/hCG surge suppresses NPPC expression by in pre-ovulatory ovaries
We used DNA microarray analyses to monitor changes in ovarian gene expression induced by the LH surge during the pre-ovulatory period. Prepubertal mice were treated with Humegon (containing FSH and LH activities) and Pregnyl (containing LH activity) to stimulate follicular maturation and ovulation, respectively. As shown in Fig. 1A (upper panel, line graph), the expression of NPPC mRNA was increased following treatment with Humegon, showing a peak between 38 and 48 h. However, treatment with Pregnyl decreased NPPC transcript levels at 2 h after treatment, followed by a rapid decline to basal levels. Although NPPA, a paralogous ligand was also expressed in the ovary throughout the experimental period, treatment with these gonadotrophins did not affect its levels (Fig. 1A, lower  panel, line graph) . To confirm DNA microarray data, we further performed real-time RT -PCR of ovarian transcripts for these genes in mice treated with PMSG followed by an ovulatory dose of hCG 48 h later (Fig. 1A, bar graphs) . Similar changes in NPPC transcript levels were observed, while NPPA levels remained unchanged. We further measured the levels of CNP derived from the NPPC gene following the pre-ovulatory LH surge by extracting ovarian samples before and after treatment of PMSG-primed mice with an ovulatory dose of hCG. As shown in Fig. 1B , high levels of ovarian CNP were found in ovaries of PMSG-primed mice. Treatment with hCG Figure 2 Cellular localization of NPPC in mouse ovaries and its regulation by gonadotrophins in granulosa cells. (A) Cell types expressing NPPC in the mouse ovary. Transcript levels of NPPC in isolated ovarian cells were quantified by real-time RT-PCR at 46 h after PMSG treatment (mean + SEM). Four samples prepared from individual animals were used. GC, mural granulosa cell; CC, cumulus cell; OC, oocyte. *P , 0.05 versus CC. (B) Effects of PMSG and hCG treatments on NPPC expression in mouse mural granulosa cells. Transcript levels of NPPC in isolated granulosa cells were quantified by real-time RT -PCR after PMSG treatment followed by hCG treatment (mean + SEM). Four samples prepared from individual animals were used. *P , 0.05 versus 46 h after PMSG treatment. (C) Effects of hCG treatment on GVBD by cultured pre-ovulatory follicles. Pre-ovulatory follicles were cultured without (control) or with hCG (1 mg/ml) for 8 h before evaluation of oocytes undergoing GVBD (n ¼ 4, 20 -30 follicles per group). *P , 0.05 versus control. (D and E) hCG suppression of NPPC mRNA levels by cultured pre-ovulatory follicles. Pre-ovulatory follicle were cultured without (control) or with hCG (1 mg/ml) for 8 h before quantification of NPPC (D) and NPPA (E) transcript levels by real-time RT -PCR (mean + SEM, n ¼ 4). Three samples in each time point prepared from 10 pre-ovulatory follicles were used. *P , 0.05 versus control. decreased ovarian CNP peptide levels by 96% within 4 h, and the CNP levels further declined to below the detection limit (7.8 pg/ml) at 12 h after hCG treatment.
Ovarian cell types expressing NPPC and regulation of NPPC transcripts by gonadotrophins in granulosa cells
Using isolated ovarian cells, we examined cell types expressing NPPC in the mouse ovary and the regulation of NPPC transcript levels by gonadotrophin treatment based on real-time RT -PCR. As shown in Fig. 2A , the NPPC mRNA was predominantly expressed in mural granulosa cells with much lower levels in cumulus cells and negligible levels in oocytes. Because it was difficult to isolate granulosa cells from early antral follicles before PMSG stimulation (0 h of PMSG), we isolated granulosa cells at 24 h after PMSG injection. As shown in Fig. 2B , treatment with a single dose of PMSG increased NPPC transcript levels in mural granulosa cells of large antral follicles in a timedependent manner. Consistent with findings in whole ovaries, the NPPC transcript was decreased after hCG stimulation and became negligible at 8 h after hCG treatment (Fig. 2B) . Based on the hCG suppression of NPPC expression, we examined whether the decline in NPPC expression induced by hCG is correlated with resumption of meiosis in pre-ovulatory oocytes. In cultured pre-ovulatory follicles, treatment with hCG for 8 h induced GVBD in oocytes (Fig. 2C) . Oocyte maturation was accompanied by decreases in transcript levels of NPPC (Fig. 2D ), but not NPPA in these follicles (Fig. 2E ).
CNP inhibition of meiosis resumption of pre-ovulatory oocytes
We further tested the ability of CNP to inhibit spontaneous and hCG-induced resumption of meiosis by cultured COCs and preovulatory follicles. In cultured COCs, .90% of oocytes exhibited gonadotrophin-independent spontaneous GVBD when COCs were punctured from pre-ovulatory follicles, whereas treatment with CNP, but not ANP, suppressed the occurrence of spontaneous GVBD of oocytes in a dose-dependent manner (Fig. 3A) . In cultured pre-ovulatory follicles, treatment with hCG induced GVBD in oocytes (Fig. 3B) . In contrast, treatment with CNP, but not ANP, suppressed the hCG-induced GVBD by 66% (Fig. 3B) .
Minimal effect of a PDE5 inhibitor on the CNP-induced inhibition of meiosis resumption of oocytes
Because PDE5 could specifically hydrolyze cumulus cell cGMP (Wang et al., 2008; Vaccari et al., 2009) , we investigated the augmentative roles of PDE5 inhibitor in the CNP-induced inhibition of GVBD in cultured COCs. As shown in Fig. 4A , the inhibition of GVBD of oocytes by treatment with a selective PDE5 inhibitor zaprinast alone was insignificant. Furthermore, the PDE inhibitor did not facilitate the inhibitory effects of CNP on meiosis resumption. In response to CNP stimuli, the levels of cGMP in both cumulus cells and oocytes were increased by 3.9- (Fig. 4B ) and 2.8-fold (Fig. 4C) , respectively. In contrast, changes in cGMP levels in these cells were minimal after treatment with both CNP and the PDE5 inhibitor, or the PDE5 inhibitor alone (Fig. 4B and C) .
Decreases in CNP levels in human follicular fluid of large antral follicles after the ovulatory hCG stimulation Because CNP produced from mural granulosa cells could stimulate cGMP generation in cumulus cells expressing its receptor, NPR2, to maintain meiotic arrest (Zhang et al., 2010) , CNP is likely secreted into follicular fluid from mural granulosa cells. To address this hypothesis, we measured the levels of CNP peptides in human follicular fluid before and after LH/hCG stimulation. As shown in Fig. 5 , the CNP peptide was present in follicular fluid of pre-ovulatory follicles (201.4 + 21.6 ng/ml) before the endogenous LH surge. After hCG treatment to induce oocyte maturation in IVF-embryo transfer patients, the levels in follicular fluid were decreased to 2.2 + 0.7 ng/ml, suggesting its suppression by hCG. 
Discussion
The present study demonstrates the suppression of NPPC expression by LH/hCG stimulation in granulosa cells of pre-ovulatory follicles, thus underscoring the role of CNP as an OMI. Furthermore, we showed that CNP treatment inhibited both spontaneous and hCG-induced GVBD of oocytes in cultured COCs and pre-ovulatory follicles, respectively. Expanding a previous study indicating that the granulosa cell ligand CNP prevents precocious meiotic resumption to coordinate ovulation synchrony as an OMI (Zhang et al., 2010) , the present findings of a decline of CNP levels by the pre-ovulatory LH/hCG surge provide further evidence for this intraovarian mechanism underlying meiotic resumption. Our data showing predominant expression of NPPC transcripts in mural granulosa cells are consistent with the previous study (Zhang et al., 2010) . Observed increases in NPPC expression in mural granulosa cells during follicle growth until LH/hCG stimuli by PMSG treatment further support the role of CNP in preventing precocious meiotic resumption. Although a previous study using semi-quantitative RT -PCR showed increases in ovarian NPPC transcript levels after eCG treatment in immature rats with a peak at 6 h followed by a decline to basal levels at 48 h of eCG (Gutkowska et al., 1999) , our data were obtained using more accurate quantitative real-time RT -PCR. Despite reported inhibitory effects of ANP in cultured COCs in rats (Tornell et al., 1990) , NPPA expression was not regulated by either PMSG or hCG in the peri-ovulatory ovaries, thus suggesting that ANP might not be important in the regulation of oocyte maturation, at least in mice. In contrast to the gonadotrophin's regulation of NPPC ligand, NPR2 receptor expressed in cumulus cells is unlikely to be regulated by the ovulatory LH stimulation, because oocyte-derived paracrine factors maintained the expression of NPR2 receptors in cumulus cells (Zhang et al., 2010) and few functional LH receptors are present in germ cells and cumulus cells (Peng et al., 1991) . OMI has been characterized as a peptide of ,2000 dalton secreted from granulosa cells into the follicular fluid capable of preventing oocyte maturation (Tsafriri and Pomerantz, 1986) . Consistent with Figure 4 The effect of CNP and PDE5 inhibitor on meiosis resumption (A) and production of cGMP (B and C) in cultured COCs. COCs were cultured without (C, control) or with CNP (100 nM) or different doses of a PDE5 inhibitor, zapriast for 4 h before evaluation of oocytes undergoing GVBD (n ¼ 4, 100 -120 COCs per group) and for 1 h before cGMP levels in cumulus cells (B) and oocytes (C) (n ¼ 4, 100 -150 COCs per group). The cGMP levels were measured by EIA (mean + SEM) and represented as fmol/total cumulus cells sorrounding one oocyte (cumulus cells) or fmol/ oocyte. *P , 0.05 versus control.
observations of increased NPPC expression, OMI concentrations in follicular fluid increased the following development of the follicle stimulated by gonadotrophins. Furthermore, the molecular weight of CNP encoded by NPPC is 2197.6, similar to the predicted peptide nature of OMI. In addition, the predominant expression of NPPC transcripts in granulosa cells and its suppression of oocyte maturation by acting through the cumulus cells are also consistent with the detection of OMI in the conditioned media of granulosa cells and the ability of OMI to act through cumulus cells in regulating oocyte meiotic resumption. Our previous studies demonstrated that CNP stimulated the generation of cGMP in cumulus cells and cumulus cell cGMP could be transferred to the oocyte to inhibit PDE3A activity, leading to elevated intra-oocyte cAMP levels essential for meiotic arrest (Norris et al., 2009; Vaccari et al., 2009; Zhang et al., 2010) . Therefore, CNP satisfies major criteria as an OMI and likely represents OMI.
After binding CNP, NPR2 expressing cumulus cells acts as a guanylyl cyclase to generate cGMP. Because PDE5 antigen was found in cumulus cells (Wang et al., 2008) and PDE5 activity was detected in follicular somatic cells, but not in oocytes (Vaccari et al., 2009) , PDE5 could hydrolyze cumulus cell cGMP, leading to regulate meiosis resumption by decreasing oocyte cGMP transported from cumulus cells. However, treatment with a PDE5 inhibitor (zaprinast) had minimal effects on GVBD in cultured COCs, and increases in oocyte cGMP following treatment with the PDE5 inhibitor alone were minimal when compared with those following treatment with CNP, consistent with previous studies (Zhang et al., 2005; Wang et al., 2008; Vaccari et al., 2009) . Furthermore, augmentative effects of the PDE5 inhibitor on CNP-induced suppression of GVBD were minimal. These results suggest that production of cumulus cell cGMP by CNP surpasses PDE5 activity to hydrolyze cGMP and maintains sufficient levels of cGMP in oocytes to inhibit GVBD before the LH surge.
In human, high levels of CNP peptides were found in follicular fluid samples before the endogenous LH surge. These concentrations are comparable with the dose of CNP (100 nM ¼ 220 ng/ml) shown to inhibit GVBD by cultured COCs in mice. However, CNP levels in follicular fluid were much lower in samples collected after hCG treatment and these follicles contain matured MII stage oocytes. Because ethical considerations prevent the treatment of oocytes from IVF-embryo transfer patients with PDE inhibitors to inhibit spontaneous GVBD after aspiration of COCs from follicles, it is difficult to study the correlation between resumption of meiosis and follicular CNP levels using patient samples. Also, due to ethical reasons, it is difficult to obtain isolated ovarian cells before LH surge to examine human ovarian cell types expressing NPPC. Future studies are required to determine the exact roles of CNP in resumption of meiosis in human.
Here, we have demonstrated gonadotrophins regulation of NPPC/ CNP expression in mouse and human ovaries and the role of CNP as a potent paracrine factor for preventing the resumption of meiosis. The important roles of ovarian paracrine factors in the regulation of oocyte maturation are becoming clear. Genome-wide analyses based on our DNA microarray data sets indicated that a limited number of ligands are induced by the pre-ovulatory LH surge to promote GVBD of the oocyte (e.g. endothelin-1 and leptin) Ye et al., 2009 ). In addition, epidermal growth factor-like ligands (Park et al., 2004) and insulin like-3 (Kawamura et al., 2004) were found to mediate the actions of LH in stimulating resumption of meiosis. Elucidation of the potentially overlaying mechanisms underlying these ovarian paracrine signaling systems could provide a better understanding of cellular mechanisms underlying meiosis resumption of oocytes and allow future formulation of new contraceptive strategies.
Figure 5 CNP peptide levels in human follicular fluids. CNP levels in human follicular fluids before the endogenous LH surge (before LH) and after exogenous hCG treatment (after hCG) were measured by ELISA (mean + SEM, n ¼ 15). *P , 0.05 versus before LH.
